These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 8584655

  • 1. Increase of survival of dopaminergic neuroblastoma in co-cultures with C-6 glioma by R-(-)-deprenyl.
    Zuo D, Yu PH.
    Prog Brain Res; 1995; 106():199-205. PubMed ID: 8584655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
    Klegeris A, McGeer PL.
    Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduction in glial fibrillary acidic protein mRNA abundance induced by (-)-deprenyl and other monoamine oxidase B inhibitors in C6 glioma cells.
    Li XM, Qi J, Juorio AV, Boulton AA.
    J Neurochem; 1993 Oct; 61(4):1573-6. PubMed ID: 8377010
    [Abstract] [Full Text] [Related]

  • 6. Enhanced tolerance of neuroblastoma cells towards the neurotoxin 6-hydroxydopamine following specific cell-cell interaction with primary astrocytes.
    Yu PH, Zuo DM.
    Neuroscience; 1997 Jun; 78(3):903-12. PubMed ID: 9153668
    [Abstract] [Full Text] [Related]

  • 7. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
    Engberg G, Elebring T, Nissbrandt H.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):841-7. PubMed ID: 1658311
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl.
    Andoh T, Chock PB, Murphy DL, Chiueh CC.
    Mol Pharmacol; 2005 Nov; 68(5):1408-14. PubMed ID: 16099847
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K, Szende B.
    Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
    [Abstract] [Full Text] [Related]

  • 13. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J.
    Vopr Med Khim; 1997 Jan; 43(6):482-93. PubMed ID: 9503565
    [Abstract] [Full Text] [Related]

  • 14. The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W, Takahashi T, Youdim M, Naoi M.
    J Neural Transm (Vienna); 2002 Apr; 109(4):467-81. PubMed ID: 11956966
    [Abstract] [Full Text] [Related]

  • 15. Neurotoxicity of levodopa on catecholamine-rich neurons.
    Mena MA, Pardo B, Casarejos MJ, Fahn S, García de Yébenes J.
    Mov Disord; 1992 Apr; 7(1):23-31. PubMed ID: 1557063
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA, Juorio AV, Berry MD, Zhu MY.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [Abstract] [Full Text] [Related]

  • 17. Glial U87 cells protect neuronal SH-SY5Y cells from indirect effect of radiation by reducing oxidative stress and apoptosis.
    Saeed Y, Xie B, Xu J, Rehman A, Hong M, Hong Q, Deng Y.
    Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):250-7. PubMed ID: 25724352
    [Abstract] [Full Text] [Related]

  • 18. Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].
    Yasar S, Justinova Z, Lee SH, Stefanski R, Goldberg SR, Tanda G.
    J Pharmacol Exp Ther; 2006 Apr; 317(1):387-94. PubMed ID: 16352699
    [Abstract] [Full Text] [Related]

  • 19. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 20. Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites.
    Szende B, Bökönyi G, Bocsi J, Kéri G, Timár F, Magyar K.
    J Neural Transm (Vienna); 2001 Oct; 108(1):25-33. PubMed ID: 11261744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.